Neurocognitive impairment (NCI) among high-risk substance users poses a substantial
barrier to reducing risk behaviors in this population. Previous work suggests that NCI is …

Cognitive impairment among populations at risk for HIV poses a significant barrier to
managing risk behaviors. The impact of HIV and several cofactors, including substance …

Although it is well established that people who use drugs (PWUDs, sus siglas en inglés) are
characterized by significant neurocognitive impairment (NCI), there has been no …

Neurocognitive (NC) impairment remains prevalent among people living with HIV (PLWH)
and may be exacerbated by alcohol and drug use. This cross-sectional study assesses the …

Controversy exists as to whether effects of HIV infection can be detected in the cognitive
profiles of substance users, with methodological differences in degree of control for …

Findings to date indicate that it is feasible to deliver a brief behavioral risk
reduction/medication adherence group intervention to HIV-infected injection drug users in a …

While numerous studies have established the adverse independent effects of clinical
conditions including neurocognitive dysfunction, psychiatric illness, and substance …

Despite the widespread use of combination antiretroviral therapy (cART), HIV-associated
neurocognitive impairment (NCI) remains a health concern. However, limited research has …

Persons with HIV (PWH) who use illicit drugs are at elevated risk for neurocognitive
impairment (NCI). This study investigated the effects of HIV disease and HIV viremia on NCI …

Background Illicit stimulant use remains a public health concern that has been associated
with multiple adverse outcomes, including cognitive deficits. The effects of stimulant use on …